FEB 21, 2017 11:06 AM PST

Our Shot To Cure Cancer

WRITTEN BY: Brook Spencer

Cancer took an estimated 600,000 lives in the United States alone in 2016–costing Americans and their families roughly $88.7 billion in cancer care. In January of 2016, The Cancer Moonshot Initiative was started in an effort to cure cancer by 2020. Globally, cancer has been considered something that can be managed, but is rarely cured. The advances that have been made since The Cancer Moonshot’s inception prove that we are closer to a cure than ever before.

One of the most profound issues this initiative has set out to overcome is the lack of availability of information and data surrounding cancer treatment and clinical trials. Cancer is a mystery; no two cancers are alike, which makes it almost impossible to choose the best treatment path for each patient. That being said, information and data surrounding trials and treatments is paramount in researching and uncovering potential cures. Making this information accessible to health care professionals allows them to make more educated decisions about patients’ treatment paths, as well as research alternative treatments on a case-by-case basis. 

The knowledge sharing fostered throughout The Cancer Moonshot has lead to several milestones, one of the most significant being in immunotherapy. Immunotherapy is a form of cancer treatment that uses a patient’s immune system and natural defenses to fight the disease. By manipulating the immune system, doctors are able to target additional proteins that help cancer cells grow. The antibodies bind to the targeted cancer cell proteins and can then either stop the cancer cells from growing or will kill them.

Since the initiative took off, clinical trial drugs are being approved in higher volume and at a much more rapid rate than ever before. This allows for an expedited process of drug inception to actual use in clinical trials. One community that is benefiting from The Cancer Moonshot is the rare disease community. More specifically, victims of the rare cancer mesothelioma. A newer immunotherapy drug for mesothelioma patients known as pembrolizumab, brand name Keytruda, has been introduced thanks to this initiative and is already showing promise as a successful treatment option.

Whether a cure to cancer is found by 2020 or not, the ancillary benefits of this initiative will be lasting. Ultimately, winning the world’s war against cancer is The Cancer Moonshot’s goal, but for the families of those affected, every victory means more time with the people they love-- which is a win in and of itself.

 

About the Author
  • Community Program Director Mesothelioma Cancer Alliance www.mesothelioma.com
You May Also Like
SEP 15, 2020
Cancer
Soy helps post-op treatment of bone cancer
SEP 15, 2020
Soy helps post-op treatment of bone cancer
New research published in the journal Acta Biomaterialia highlights the post-operative benefits of soy in treatment ...
SEP 16, 2020
Cancer
I'm addicted to the sun, are you?
SEP 16, 2020
I'm addicted to the sun, are you?
New research published in the Journal of Investigative Dermatology reports evidence that some people are geneticall ...
SEP 28, 2020
Cancer
A New Transcriptomics Program in the Works Glioma Diagnosis
SEP 28, 2020
A New Transcriptomics Program in the Works Glioma Diagnosis
The future of medicine is “personalized healthcare.” However, testing remains a critical hurdle researcher&r ...
SEP 30, 2020
Cancer
Chemokines Could be the Key in Controlling Glioma Stem Cells
SEP 30, 2020
Chemokines Could be the Key in Controlling Glioma Stem Cells
The transformation of a healthy cell into a cancerous one often comes with a slew of cellular signaling changes.  T ...
SEP 30, 2020
Cancer
How to avoid endocrine disrupting chemicals in your life
SEP 30, 2020
How to avoid endocrine disrupting chemicals in your life
While few people actually enjoy reading product labels and ingredients, a new study from Silent Spring Institute suggest ...
OCT 14, 2020
Immunology
Self-Healing Microcapsules Make Promising Leukemia Vaccines
OCT 14, 2020
Self-Healing Microcapsules Make Promising Leukemia Vaccines
Leukemia is a cancer affecting tissues in the body that produce blood cells, including the bone marrow and the lymphatic ...
Loading Comments...